Addressing Rising Hospital Care Costs: Committee Insights
The Committee on Ways and Means recently examined the substantial costs linked to hospital care during a hearing that featured testimonies from leaders across various health systems. Discussions highlighted the significant impact of high hospital prices on overall healthcare costs and federal expenditure. Chaired by Jason Smith, the committee explored potential reforms targeting site-of-service payments, the tax-exempt status of nonprofit hospitals, and the 340B drug discount program. These discussions arrive at a critical juncture as federal healthcare spending escalates, with the Medicare Hospital Insurance trust fund projected to face insolvency within the next seven years.
Hospital care is the largest segment of healthcare spending in the United States, comprising approximately 31% of National Health Expenditures, or about 5.5% of GDP, while accounting for 37% of Medicare spending alone. Hospital expenditures have consistently risen, with an increase of 11% in 2023 and 9% in 2024. Projections suggest an average annual growth of nearly 6% through 2033, emphasizing the pressing need for effective cost management solutions.
The rising prices of hospital care partly drive the escalating costs. Medicare's payments to hospitals tend to be two to four times higher than those paid to private clinics for comparable services, while commercial insurance rates average 2.5 times those of Medicare. These disparities highlight the necessity for strategic interventions to manage these costs effectively.
During the hearing, officials proposed several strategies to address these high prices. Beyond the proposed reforms, additional measures such as reference pricing for the Federal Employees Health Benefits program, implementing caps on commercial hospital prices relative to Medicare rates, and adjustments to Disproportionate Share Hospital payments were discussed. Suggestions also included reducing reimbursements for bad debt, revising Graduate Medical Education funding, enhancing price transparency, and rebasing payments to align with current sequester levels, indicating a wide array of policy options on the table.
To comprehensively address healthcare costs, lawmakers are encouraged to assess policy options related to Medicare Advantage, prescription drug expenses, cost-sharing mechanisms, Medicaid, and the Affordable Care Act. With health costs continually climbing and hospital expenses forming a significant portion of total health spending, there is an urgent need to deliberate on these critical policy alternatives.
The Committee on Ways and Means' focus on reducing healthcare costs occurs against a backdrop of unprecedented national debt, which has reached historical peacetime highs, with the debt ceiling set at $41.1 trillion by the One Big Beautiful Bill Act of 2025. In facing these fiscal challenges, prioritizing effective policy solutions to curb hospital costs remains paramount for ensuring both economic and healthcare sustainability.